Nemescu, D., Tanasa, I.A., Stoian, D.L., Navolan, D.B. and Vinturache, A.E. (2020) Conservative in utero Treatment of Fetal Dyshormonogenetic Goiter with Levothyroxine, a Systematic Literature Review. Experimental and Therapeutic Medicine, 20, 2434-2438.
https://doi.org/10.3892/etm.2020.8794

has been cited by the following article:

• TITLE: Prenatal Diagnosis and Management of Fetal Goiter Treated Successfully with Intra-Amniotic Levothyroxine

  AUTHORS: Valentina Corda, Cristina Peddes, Ambra Iuculano, Giovanni Monni

  KEYWORDS: Fetal Goiter, Prenatal Diagnosis, Prenatal Therapy, Amniocentesis, Fetal Thyroid, Fetal Ultrasound, Levothyroxine (L-T4)

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.11 No.1, January 26, 2021

  ABSTRACT: Goiter is an enlargement of the thyroid gland which can be associated with a number of complications both for the mother and the fetus. A 34-year-old pregnant woman with normal thyroid function was referred to our Department of Obstetrics and Gynecology at Microcitemico Pediatric Hospital, Cagliari, for suspected fetal goiter at 32 gestational weeks. The case was monitored regularly by ultrasound and treated successfully with intra-amniotic levothyroxine (L-T4) administration. Fetal goiter was observed to decrease after this treatment and the thyroid ultrasound findings were also normal both at birth and in subsequent follow-ups. Our case report confirms the feasibility of conservative treatment with L-T4, which can effectively prevent complications related to fetal goiter.